Publications by authors named "Koen Degeest"

Claim this Profile
P
Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study.
Robert F Ozols, Brian N Bundy, Benjamin E Greer, Jeffrey M Fowler, Daniel Clarke-Pearson, Koen DeGeest

J Clin Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The addition of paclitaxel to doxorubicin and cisplatin and volume-directed radiation does not improve overall survival (OS) or long-term recurrence-free survival (RFS) in advanced endometrial cancer (EC): A randomized phase III NRG/Gynecologic Oncology Group (GOG) study.
Nick M Spirtos, Danielle Enserro, Howard D Homesley, Susan K Gibbons, David Cella, Koen DeGeest

Gynecol Oncol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SSRI use and clinical outcomes in epithelial ovarian cancer.
Desiré K Christensen, Guillermo N Armaiz-Pena, Edgardo Ramirez, Koji Matsuo, Bridget Zimmerman, Koen DeGeest

Oncotarget· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biobehavioral and neuroendocrine correlates of antioxidant enzyme activity in ovarian carcinoma.
Jennifer L Bayer, Douglas R Spitz, Desire Christensen, Michael L McCormick, Donna Farley, Koen DeGeest

Brain Behav Immun· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diurnal cortisol and survival in epithelial ovarian cancer.
Andrew Schrepf, Premal H Thaker, Michael J Goodheart, David Bender, George M Slavich, Koen DeGeest

Psychoneuroendocrinology· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Focal adhesion kinase: an alternative focus for anti-angiogenesis therapy in ovarian cancer.
Rebecca L Stone, Keith A Baggerly, Guillermo N Armaiz-Pena, Yu Kang, Angela M Sanguino, Koen DeGeest

Cancer Biol Ther· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of LEF1 in endometrial gland formation and carcinogenesis.
Dawne N Shelton, Hubert Fornalik, Traci Neff, Soo Yeun Park, David Bender, Koen DeGeest

PLoS One· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cortisol and inflammatory processes in ovarian cancer patients following primary treatment: relationships with depression, fatigue, and disability.
Andrew Schrepf, Lauren Clevenger, Desire Christensen, Koen DeGeest, David Bender

Brain Behav Immun· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sleep disturbance, cytokines, and fatigue in women with ovarian cancer.
Lauren Clevenger, Andrew Schrepf, Desire Christensen, Koen DeGeest, David Bender

Brain Behav Immun· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paraneoplastic thrombocytosis in ovarian cancer.
Rebecca L Stone, Alpa M Nick, Iain A McNeish, Frances Balkwill, Hee Dong Han, Koen DeGeest

N Engl J Med· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A single-institution evaluation of factors important in fallopian tube carcinoma recurrence and survival.
Alireza A Shamshirsaz, Thomas Buekers, Koen Degeest, David Bender, Gideon Zamba

Int J Gynecol Cancer· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized phase III trial of IV carboplatin and paclitaxel × 3 courses followed by observation versus weekly maintenance low-dose paclitaxel in patients with early-stage ovarian carcinoma: a Gynecologic Oncology Group Study.
Robert S Mannel, Mark F Brady, Elise C Kohn, Parviz Hanjani, Masamichi Hiura, Koen Degeest

Gynecol Oncol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I study with an expanded cohort to assess the feasibility of intraperitoneal carboplatin and intravenous paclitaxel in untreated ovarian, fallopian tube, and primary peritoneal carcinoma: A Gynecologic Oncology Group study.
Mark A Morgan, Michael W Sill, Keiichi Fujiwara, Benjamin Greer, Stephen C Rubin, Koen Degeest

Gynecol Oncol· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of two topotecan regimens evaluated in recurrent platinum-sensitive ovarian, fallopian tube or primary peritoneal cancer: a Gynecologic Oncology Group Study (GOG 146Q).
Thomas J Herzog, Michael W Sill, Joan L Walker, David O'Malley, Mark Shahin, Koen DeGeest

Gynecol Oncol· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Social isolation is associated with elevated tumor norepinephrine in ovarian carcinoma patients.
Susan K Lutgendorf, Koen DeGeest, Laila Dahmoush, Donna Farley, Frank Penedo

Brain Behav Immun· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity of sorafenib in recurrent ovarian cancer and primary peritoneal carcinomatosis: a gynecologic oncology group trial.
Daniela Matei, Michael W Sill, Heather A Lankes, Koen DeGeest, Robert E Bristow

J Clin Oncol· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive and prognostic angiogenic markers in a gynecologic oncology group phase II trial of bevacizumab in recurrent and persistent ovarian or peritoneal cancer.
Ernest S Han, Robert A Burger, Kathleen M Darcy, Michael W Sill, Leslie M Randall, Koen Degeest

Gynecol Oncol· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preservation of immune function in cervical cancer patients during chemoradiation using a novel integrative approach.
Susan K Lutgendorf, Elizabeth Mullen-Houser, Daniel Russell, Koen Degeest, Geraldine Jacobson

Brain Behav Immun· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diurnal cortisol dysregulation, functional disability, and depression in women with ovarian cancer.
Aliza Z Weinrib, Sandra E Sephton, Koen Degeest, Frank Penedo, David Bender

Cancer· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II evaluation of paclitaxel and carboplatin in the treatment of carcinosarcoma of the uterus: a Gynecologic Oncology Group study.
Matthew A Powell, Virginia L Filiaci, Peter G Rose, Robert S Mannel, Parviz Hanjani, Koen Degeest

J Clin Oncol· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adrenergic modulation of focal adhesion kinase protects human ovarian cancer cells from anoikis.
Anil K Sood, Guillermo N Armaiz-Pena, Jyotsnabaran Halder, Alpa M Nick, Rebecca L Stone, Koen DeGeest

J Clin Invest· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II evaluation of bortezomib in the treatment of recurrent platinum-sensitive ovarian or primary peritoneal cancer: a Gynecologic Oncology Group study.
Carol Aghajanian, John A Blessing, Kathleen M Darcy, Gary Reid, Koen DeGeest

Gynecol Oncol· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized phase III trial in advanced endometrial carcinoma of surgery and volume directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: A Gynecologic Oncology Group study.
Howard D Homesley, Virginia Filiaci, Susan K Gibbons, Harry J Long, David Cella, Koen DeGeest

Gynecol Oncol· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucose as a prognostic factor in ovarian carcinoma.
Donald M Lamkin, Douglas R Spitz, Mian M K Shahzad, Bridget Zimmerman, Daniel J Lenihan, Koen Degeest

Cancer· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biobehavioral influences on matrix metalloproteinase expression in ovarian carcinoma.
Susan K Lutgendorf, Donald M Lamkin, Nicholas B Jennings, Jesusa M G Arevalo, Frank Penedo, Koen DeGeest

Clin Cancer Res· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis